{"slug":"nad-plus-trigeminal","verification":{"valid":true,"entries":1,"head":"89c98bda1f579ed714f6ae911c8b9209dc8f0ebce4732b30bb09111a6066de97"},"count":1,"models":["grok/grok-4.3"],"yield":{"passes":1,"energy_spent_rows":0,"total_cost_usd":0.043893,"waste_cost_usd":0,"total_tokens":32867,"material_outputs":0,"usd_per_output":null,"models":[{"model":"grok/grok-4.3","passes":1,"cost_usd":0.043893,"tokens_total":32867,"outputs":0,"waste_passes":0,"usd_per_output":null}],"constraints":{"constitution":"/api/articles/constitution","collaborate_schema":"POST /api/protocol/collaborate","pricing_ppm":{"grok-4.3":[1.25,2.5],"grok/grok-4.3":[1.25,2.5],"grok-build-0.1":[1,2],"kimi/moonshot-v1-8k":[0.15,0.15],"gemini/gemini-2.5-flash":[0.075,0.3],"gemini/gemini-2.0-flash-lite":[0.075,0.3],"openai/gpt-4o":[2.5,10],"openai/gpt-4o-mini":[0.15,0.6],"system/reflex":[0,0],"ingest:deterministic":[0,0],"fill-slots":[0,0]}}},"contributions":[{"seq":0,"id":"k1","ts":"2026-06-30T01:39:58.363Z","model":"grok/grok-4.3","role":"writer","action":"redraft","payload":{"title":"NAD+ for Trigeminal: Mitochondrial Repair in Nerve Pain Models","register":"source_ledger","body":"## What's breaking down\n\nTrigeminal neuralgia involves sudden, severe facial pain from issues with the trigeminal nerve. Common layers include neurovascular compression causing nerve root distortion or atrophy, demyelination of afferents, elevated oxidative stress, and mitochondrial impairment in the trigeminal ganglion. These create hyperexcitability through altered ion channels and inflammatory signaling. Breakdown outruns natural repair when mitochondrial energy production drops, sustaining ectopic firing and sensitization.\n\n## Why NAD+ might help you\n\nNAD+ supports cellular energy production inside mitochondria. In the trigeminal ganglion, mitochondrial defects lower NAD+ levels and NAD+/NADH ratios, impairing the electron transport chain.\n\n1. If mitochondrial dysfunction sits in your pain pathway, boosting NAD+ with precursors like NR replenishes the pool.\n2. Restored NAD+ activates Sirt1, which downregulates pain-related genes and inflammatory pathways.\n3. Therefore for you: If that layer is part of your problem, NAD+ is discussed because it targets repair (tissue) — not because it masks pain.\n\n## How these fit together\n\nSingle-compound focus — NAD+ targets the cellular energy layer in trigeminal ganglion neurons.\n\n## What the evidence actually shows\n\nA 2025 mouse study used chronic constriction injury of the infraorbital nerve (CCI-IoN) to model trigeminal neuropathic pain. Researchers performed RNA-seq on the trigeminal ganglion and found broad downregulation of mitochondrial genes plus reduced NAD+ levels. NR supplementation raised NAD+, improved mitochondrial fitness, reduced mechanical allodynia, and worked mainly through Sirt1 to suppress inflammation and pain genes. This is preclinical (animal model) evidence only. No human trials specific to NAD+ or NR for trigeminal neuralgia appear in current searches. Broader reviews link NAD+ decline to mitochondrial dysfunction and oxidative stress in peripheral neuropathic pain, but again at mechanistic and animal levels.\n\n## What scientists say\n\nThe study authors conclude that targeting mitochondrial dysfunction via NAD+ replenishment offers a novel approach to craniofacial pain. They note the analgesic effect of NR depends on Sirt1 and involves downregulation of ion channels like HCN2 and inflammatory pathways. Human data on NAD+ restoration for nerve pain remain absent; ongoing work explores NAD+ in other neuropathic conditions through mitochondrial mechanisms.\n\n## What people say on Reddit\n\nAnecdotal reports appear in trigeminal neuralgia and related subreddits. Users mention trying NAD+ or B3 forms for energy during pain flares or alongside other approaches, with mixed comments on perceived benefits for fatigue rather than direct pain relief. One post links NAD+ discussion to B12 in a “double whammy” pain thread. These remain individual experiences without controlled reporting.\n\n## What people say on X\n\nLimited public posts tie NAD+ specifically to trigeminal issues. Mentions are sparse and mostly general energy or supplement discussions overlapping with neuropathic pain communities.\n\n## What we do not know\n\nNo published human trials test NAD+ precursors for trigeminal neuralgia. Long-term effects on nerve repair in humans, optimal delivery methods, and interactions with common TN medications are unknown. Translation from mouse CCI-IoN models to classical TN with vascular compression requires further study.\n\n## Safety and limits\n\nAnimal studies report NAD+ precursor use without major adverse signals in the cited model. Human safety data for NAD+ boosting come from other contexts and show generally good tolerability at studied doses, though individual responses vary. This remains an area of active research without established clinical protocols for this condition.","claims":[{"id":"c1","text":"A 2025 mouse study (CCI-IoN model) found mitochondrial gene downregulation and reduced NAD+ in the trigeminal ganglion; NR supplementation improved mitochondrial function, activated Sirt1, downregulated pain and inflammatory genes, and reduced mechanical allodynia.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s2"],"source_status":"sourced","why_material":"Direct evidence linking NAD+ restoration to trigeminal neuropathic pain relief in an animal model of nerve injury.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:39:57.691Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"No human clinical trials specifically testing NAD+ or NR for trigeminal neuralgia were identified in searches of PubMed and related databases.","section":"What the evidence actually shows","tier":"human","source_ids":["s2"],"source_status":"sourced","why_material":"Clarifies the gap between animal data and clinical application for this exact use.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:39:57.691Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"Reddit users in trigeminal neuralgia communities report personal experimentation with NAD+ or B3 forms, often noting effects on energy rather than direct pain resolution.","section":"What people say on Reddit","tier":"anecdotal","source_ids":["s3"],"source_status":"sourced","why_material":"Captures real-world user reports separate from controlled evidence.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:39:57.691Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s2","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/39528053/","title":"Restoration of mitochondrial function alleviates trigeminal neuropathic pain in mice","quote":"Our findings demonstrated that rejuvenating mitochondria by boosting NAD + levels enhanced mitochondrial fitness and significantly ameliorated trigeminal neuropathic pain.","link_status":"ok","quote_status":"unverified"},{"id":"s3","type":"reddit","url":"https://www.reddit.com/r/TrigeminalNeuralgia/comments/193maap/double_whammy/","title":"Double Whammy","quote":"B12 and B3( NAD +) especially.","link_status":"ok","quote_status":"unverified"}]},"rationale":"","tokens_in":30620,"tokens_out":2247,"cost":0.0438925,"prev_hash":"genesis","hash":"89c98bda1f579ed714f6ae911c8b9209dc8f0ebce4732b30bb09111a6066de97"}]}